EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Global seroprevalence of Zika virus in asymptomatic individuals: A systematic review

Paola Mariela Saba Villarroel iD, Rodolphe Hamel, Nuttamonpat Gumpangseth, Sakda Yainoy, Phanit Koomhin, Dorothée Missé, Sineewanlaya Wichit iD

PLOS Neglected Tropical Diseases · 17.04.2024 · 18 (4) · e0011842

DOI: 10.1371/journal.pntd.0011842 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 17.04.2024. Verfasst von Paola Mariela Saba Villarroel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology and Applied Technology, Faculty of Medical Technology, Mahidol University, Nakhon Pathom, Thailand. Hauptthemen laut MEDLINE: Zika Virus Infection, Zika Virus, Antibodies, Viral. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mahidol University, National Research Council of Thailand (NRCT), Office of the Permanent Secretary, Ministry of Higher Education, Science, Research and Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Zika virus (ZIKV) has spread to five of the six World Health Organization (WHO) regions. Given the substantial number of asymptomatic infections and clinical presentations resembling those of other arboviruses, estimating the true burden of ZIKV infections is both challenging and essential. Therefore, we conducted a systematic review and meta-analysis of seroprevalence studies of ZIKV IgG in asymptomatic population to estimate its global impact and distribution. Methodology/Principal findings We conducted extensive searches and compiled a collection of articles published from Jan/01/2000, to Jul/31/2023, from Embase, Pubmed, SciELO, and Scopus databases. The random effects model was used to pool prevalences, reported with their 95% confidence interval (CI), a tool to assess the risk of study bias in prevalence studies, and the I 2 method for heterogeneity (PROSPERO registration No. CRD42023442227). Eighty-four studies from 49 countries/territories, with a diversity of study designs and serological tests were included. The global seroprevalence of ZIKV was 21.0% (95%CI 16.1%-26.4%). Evidence of IgG antibodies was identified in all WHO regions, except for Europe. Seroprevalence correlated with the epidemics in the Americas (39.9%, 95%CI:30.0–49.9), and in some Western Pacific countries (15.6%, 95%CI:8.2–24.9), as well as with recent and past circulation in Southeast Asia (22.8%, 95%CI:16.5–29.7), particularly in Thailand. Additionally, sustained low circulation was observed in Africa (8.4%, 95%CI:4.8–12.9), except for Gabon (43.7%), and Burkina Faso (22.8%). Although no autochthonous transmission was identified in the Eastern Mediterranean, a seroprevalence of 16.0% was recorded. Conclusions/Significance The study highlights the high heterogeneity and gaps in the distribution of seroprevalence. The implementation of standardized protocols and the development of tests with high specificity are essential for ensuring a valid comparison between studies. Equally crucial are vector surveillance and control methods to reduce the risk of emerging and re-emerging ZIKV outbreaks, whether caused by Ae . aegypti or Ae . albopictus or by the Asian or African ZIKV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zika Virus InfectionZika VirusAntibodies, ViralHumansSeroepidemiologic StudiesImmunoglobulin GGlobal HealthAsymptomatic Infections

Substanzen

Antibodies, ViralImmunoglobulin G

Autor:innen und Institutionen

  • Department of Clinical Microbiology and Applied Technology, Faculty of Medical Technology, Mahidol University, Nakhon Pathom, Thailand.
  • Viral Vector Joint unit and Joint Laboratory, Mahidol University, Nakhon Pathom, Thailand.
  • MIVEGEC, Univ. Montpellier, CNRS, IRD, Montpellier, France.
  • Center of Excellence in Innovation on Essential Oil, Walailak University, Nakhonsithammarat, Thailand.

ORCID-Profile: Paola Mariela Saba Villarroel, Sineewanlaya Wichit

Förderung

  • Mahidol University
  • National Research Council of Thailand (NRCT)
  • Office of the Permanent Secretary, Ministry of Higher Education, Science, Research and Innovation

Zitieren

APA

Saba Villarroel, P. M., Hamel, R., Gumpangseth, N., Yainoy, S., Koomhin, P., Missé, D., & Wichit, S. (2024). Global seroprevalence of Zika virus in asymptomatic individuals: A systematic review. PLOS Neglected Tropical Diseases, 18(4), e0011842. https://doi.org/10.1371/journal.pntd.0011842

Vancouver

Saba Villarroel PM, Hamel R, Gumpangseth N, Yainoy S, Koomhin P, Missé D, et al. Global seroprevalence of Zika virus in asymptomatic individuals: A systematic review. PLOS Neglected Tropical Diseases. 2024;18(4):e0011842. doi:10.1371/journal.pntd.0011842

BibTeX
@article{SabaVillarroel2024,
  author = {Saba Villarroel, Paola Mariela and Hamel, Rodolphe and Gumpangseth, Nuttamonpat and Yainoy, Sakda and Koomhin, Phanit and Missé, Dorothée and Wichit, Sineewanlaya},
  title = {Global seroprevalence of Zika virus in asymptomatic individuals: A systematic review},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  volume = {18},
  number = {4},
  pages = {e0011842},
  doi = {10.1371/journal.pntd.0011842}
}
Kostenlos starten →